| 靶点: |
Microbial Metabolite;D2 Dopamine Receptor |
| 体内研究: |
Dopamine hydrochloride (50 mg/kg;腹腔注射;1-7 天) 强烈且选择性地抑制 VPF/VEGF 的血管透化和血管生成活性。 |
| 参考文献: |
1. Juárez Olguín H, et al. The Role of Dopamine and Its Dysfunction as a Consequence of Oxidative Stress. Oxid Med Cell Longev. 2016;2016:9730467. 2. Basu S, et al. The neurotransmitter dopamine inhibits angiogenesis induced by vascular permeability factor/vascular endothelial growth factor. Nat Med. 2001 May;7(5):569-74. |
| 保存条件: |
-80℃(运输条件:冰袋低温运输) |
| 配置溶液浓度参考: |
|
1mg |
5mg |
10mg |
| 1 mM |
5.273 ml |
26.366 ml |
52.731 ml |
| 5 mM |
1.055 ml |
5.273 ml |
10.546 ml |
| 10 mM |
0.527 ml |
2.637 ml |
5.273 ml |
| 50 mM |
0.105 ml |
0.527 ml |
1.055 ml |
|
| 注意: |
部分产品我司仅能提供部分信息,我司不保证所提供信息的权威性,仅供客户参考交流研究之用。 |